Evoqua Water Technologies, a water treatment solutions firm, celebrated the opening of its new manufacturing facility in Singapore, furthering the company’s investment in Asia-Pacific (APAC) as demand continues to grow for innovative water treatment solutions in the region.
What does the new facility mean for APAC?
The 19,000 square foot state-of-the-art facility will be the global manufacturing facility for Evoqua’s Ionpure® Continuous Electrodeionization (CEDI) products. Evoqua’s Ionpure brand was the first to commercialize CEDI for water purification, a chemical-free, self-regenerating technology that provides a consistent flow of high-quality deionized water.
The facility supports efforts to localize production to better serve the increasing demand for ultrapure water solutions in the APAC, mostly in the microelectronics and pharmaceutical industries. The new facility is expected to bring approximately 30 jobs to the region.
What were the executive’s thoughts on the facility?
“The establishment of this manufacturing facility supports Evoqua’s growth and market development plans for the APAC market. Our expanded presence allows us to meet the growing needs of the APAC, strengthening our commitment to helping our clients across the region address their critical water treatment needs,” said Ron Keating, Evoqua’s CEO.
To inaugurate the event, Mr. Keating was joined by Hervé Fages, Evoqua’s Executive Vice President and Applied Product Technologies Segment President, for the ribbon-cutting.